Investment
Features
FeesSafety
Academy
More
Pluang+

Compare AbCellera Biologics Inc (ABCL) vs LyondellBasell Industries NV (LYB) Price & Performance

AbCellera Biologics IncTrade
LyondellBasell Industries NVTrade

Price performance (Past 24H)

Key statistics

AbCellera Biologics Inc vs LyondellBasell Industries NV — how do they compare? AbCellera Biologics Inc trades at $8.97 (market cap $2.85B), while LyondellBasell Industries NV trades at $63.98 (market cap $20.24B). The key difference: LyondellBasell Industries NV is far larger — about 7.1× AbCellera Biologics Inc's market cap, and LyondellBasell Industries NV pays a 6.58% dividend while AbCellera Biologics Inc pays none. Which is the better fit depends on your goals.

ABCLLYB
Market Cap
$2.85B$20.24B
Sector
HealthBasic Materials
52-Week High
$9.76$82.38
52-Week Low
$2.78$42.28
Enterprise Value
$2.45B$31.83B
Dividend Yield
6.58%

Returns comparison

Trailing returns across standard periods

About AbCellera Biologics Inc

AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.

Read more on ABCL

About LyondellBasell Industries NV

LyondellBasell Industries NV is a petrochemical producer with operations in the U.S. and Europe. It operates in six segments: Olefins and Polyolefins-Americas (O&P-Americas), Olefins and Polyolefins-Europe, Asia, International (O&P-EAI), Intermediates and Derivatives (I&D), Advanced Polymer Solutions (APS), Refining and Technology. The company is a major producer of polyethylene, the world's largest producer of polypropylene, and the second- largest producer of propylene oxide. Its chemicals are used in various consumer and industrial end products. Substantially, all of the company's revenue is derived from product sales.

Read more on LYB